A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic or Open Liver Resection for Patients with BCLC Stage 0-A Hepatocellular Carcinoma.

医学 倾向得分匹配 肝细胞癌 阶段(地层学) 前瞻性队列研究 外科 入射(几何) 肝切除术 肝癌 内科学
作者
Peng Zhu,Wei Liao,Wan-Guang Zhang,Lin Chen,Chang Shu,Zhi-Wei Zhang,Zhi-Yong Huang,Yi-Fa Chen,Wan Yee Lau,Bi-Xiang Zhang,Xiao-Ping Chen
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
被引量:1
标识
DOI:10.1097/sla.0000000000005380
摘要

To compare the short- and long-term outcomes of robot-assisted (RALR), laparoscopic (LLR), or open liver resection (OLR) in the treatment of BCLC stage 0-A hepatocellular carcinoma (HCC).Following the Balliol IDEAL classification, long-term oncological outcomes can be used to evaluate the value of minimally invasive techniques in the treatment of HCC, and to assess whether they should become a standard practice.Data from prospective cohorts of patients with BCLC stage 0-A HCC who underwent curative liver resection using OLR, LLR, or RALR at Tongji Hospital were reviewed. The short-term and long-term oncological outcomes of these three different surgical approaches after adequate follow-up were compared using propensity score matching to reduce selection bias.Of 369 patients included in this study (71, RALR; 141, LLR; and 157, OLR), 56 patients in each of the three groups were chosen for further comparison, after PSM. In the minimally invasive group (RALR+LLR), both the operative time and duration of Pringle's maneuver were significantly longer than those in the OLR group; however, the length of hospital stay was significantly shorter. There were no significant differences in the other intraoperative parameters and the incidence of postoperative complications among the three groups. HCC recurrence in the minimally invasive group when compared with the OLR group was characterized by a significantly higher proportion of single lesion or early stage HCC. However, there were no significant differences in the 5-year disease-free survival (DFS) (63.8%, 54.4%, and 50.6%) or overall survival rates (80.8%, 78.6%, and 75.7%, respectively) among the three groups. Clinically significant portal hypertension (CSPH) was the only risk factor that negatively affected the 5-year DFS rate. Multivariate Cox regression analysis showed that CSPH, serum alpha-fetoprotein level (≥400 ng/ml), and Edmondson-Steiner grading (III+IV) were independent risk factors for poor long-term survival.Both robotic and laparoscopic hepatectomies were safe and effective for patients with BCLC stage 0-A HCC when compared with open hepatectomy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阿坤完成签到,获得积分10
1秒前
dd发布了新的文献求助10
2秒前
桐桐应助小智采纳,获得10
2秒前
九川完成签到,获得积分10
2秒前
混子完成签到,获得积分10
2秒前
2秒前
3秒前
Wang完成签到,获得积分10
3秒前
星辰大海应助Ll采纳,获得10
3秒前
Jasper应助妮儿采纳,获得10
4秒前
tododoto完成签到,获得积分10
4秒前
4秒前
淙淙柔水完成签到,获得积分0
4秒前
杳鸢应助mc1220采纳,获得10
4秒前
rosa完成签到,获得积分10
4秒前
郑小七发布了新的文献求助10
5秒前
Tianxu Li完成签到,获得积分10
6秒前
6秒前
九川发布了新的文献求助10
7秒前
Lucas应助无限的隶采纳,获得10
7秒前
胡雅琴完成签到,获得积分10
7秒前
sakurai完成签到,获得积分10
8秒前
清歌扶酒关注了科研通微信公众号
8秒前
二尖瓣后叶举报ww求助涉嫌违规
8秒前
烟花应助轻松笙采纳,获得10
8秒前
沉默凡桃完成签到,获得积分10
9秒前
9秒前
luuuuuing发布了新的文献求助30
9秒前
啦啦啦完成签到,获得积分10
9秒前
小可发布了新的文献求助10
9秒前
10秒前
LKGG完成签到 ,获得积分10
10秒前
11秒前
11秒前
11秒前
周士乐发布了新的文献求助10
11秒前
Sunshine发布了新的文献求助10
11秒前
呼吸之野完成签到,获得积分10
12秒前
害怕的小懒虫完成签到,获得积分10
12秒前
思源应助Nefelibata采纳,获得10
13秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759